Form D · Biotechnology

Meru Biotechnologies, Inc.

Richmond, VA · CIK 0001785460

Offering snapshot reported Mar 24, 2021 · SEC filing

Reported sold
$200K
Offering amount: $1.2M
Investors reported
1
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Oct 19, 2020
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$100K$200KNov 2, 2020: $200,000.00Nov 2, 2020Mar 24, 2021: $200,000.00Mar 24, 2021

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 24, 2021Amendment$200,000$0vs Nov 2, 20201SEC filing
Nov 2, 2020Initial$200,000No comparison1SEC filing
Aug 30, 2019Initial$1,000,000No comparison1SEC filing

Offering details

Securities
Debt
Exemptions
06c
Duration over one year
No
Business combination
No
Sales commissions
$52K (estimated)
Finders' fees
$0
Form D file number
021-379430
The Broker Dealer (see Item 12) will receive 6.5% cash payment, plus warrants, and so may receive up to $52,000 if the full amount of the offering is subscribed. No commission is due with respect to the the first $200,000 sold.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
First Liberties Securities, Inc. (dba First Liberties Financial)14432First Liberties Securities, Inc. (dba First Liberties Financial) · CRD 14432

Source: Form D, filed Mar 24, 2021. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Daniel Rodenhaver Director, Executive
Theresa Schaub Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
800 E Leigh Street
Richmond, VA, 23219